Editorial Comment to High performance of 5‐aminolevulinic acid‐induced fluorescent selective upper tract urinary cytology

esical instillation of 5-aminolevulinic acid: the fluorescent metabolite is limited to urothelial cells. Urology 1994; 44: 676–81. 10 Jocham D, Stepp H, Waidelich R. Photodynamic diagnosis in urology: stateof-the-art. Eur. Urol. 2008; 53: 1138–48. 11 Bier S, Hennenlotter J, Esser M et al. Performance of urinary markers for detection of upper tract urothelial carcinoma: Is upper tract urine more accurate than urine from the bladder? Dis. Markers 2018; 2018: 5823870. 12 Yamamichi G, Nakata W, Tani M et al. High diagnostic efficacy of 5aminolevulinic acid-induced fluorescent urine cytology for urothelial carcinoma. Int. J. Clin. Oncol. 2019; 24: 1075–80. 13 Akita H, Kikuchi E, Hayakawa N et al. Performance of diffusion-weighted MRI post-CT urography for the diagnosis of upper tract urothelial carcinoma: comparison with selective urine cytology sampling. Clin. Imaging 2018; 52: 208–15. 14 Kiesslich T, Helander L, Illig R et al. Real-time analysis of endogenous protoporphyrin IX fluorescence from d-aminolevulinic acid and its derivatives reveals distinct timeand dose-dependent characteristics in vitro. J. Biomed. Opt. 2014; 19: 085007. 15 Potretzke AM, Knight BA, Vetter JM et al. Diagnostic utility of selective upper tract urinary cytology: a systematic review and meta-analysis of the literature. Urology 2016; 96: 35–43. 16 Miyake M, Nakai Y, Anai S et al. Diagnostic approach for cancer cells in urine sediments by 5-aminolevulinic acid-based photodynamic detection in bladder cancer. Cancer Sci. 2014; 105: 616–22. 17 Gruschwitz T, Gajda M, Enkelmann A et al. FISH analysis of washing urine from the upper urinary tract for the detection of urothelial cancers. Int. Urol. Nephrol. 2014; 46: 1769–74. 18 Todenh€ofer T, Hennenlotter J, K€uhs U et al. Influence of urinary tract instrumentation and inflammation on the performance of urine markers for the detection of bladder cancer. Urology 2012; 79: 620–4. 19 Kata SG, Aboumarzouk OM, Zreik A et al. Photodynamic diagnostic ureterorenoscopy: a valuable tool in the detection of upper urinary tract tumour. Photodiagnosis Photodyn. Ther. 2016; 13: 255–60. 20 Guo RQ, Hong P, Xiong GY et al. Impact of ureteroscopy before radical nephroureterectomy for upper tract urothelial carcinomas on oncological outcomes: a meta-analysis. BJU Int. 2018; 121: 184–93. 21 Inoue K, Fukuhara H, Shimamoto T et al. Comparison between intravesical and oral administration of 5-aminolevulinic acid in the clinical benefit of photodynamic diagnosis for nonmuscle invasive bladder cancer. Cancer 2012; 118: 1062–74. 22 Krause FS, Rauch A, Schrott KM, Engehausen DG. Clinical decisions for treatment of different staged bladder cancer based on multitarget fluorescence in situ hybridization assays? World J. Urol. 2006; 24: 418–22. 23 Gomella LG, Mann MJ, Cleary RC et al. Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: the largest single-institution experience to date. Can. J. Urol. 2017; 24: 8620–6. 24 Matsuyama H. Could basic research shed light on false positivity in photodynamic diagnosis? Int. J. Urol. 2012; 19: 695–6.